Element Squared’s Halozyme HALO Stock Holding History

Element Squared’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,726	Closed	-$1.19M	–	58
2025 Q4	$1.19M	Buy	+17,726	New	+$1.19M	0.65%	40

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Element Squared's HALO Position: Q1 2026 in Review

Element Squared sold out of Halozyme (HALO) in Q1 2026, closing a stake of 17,726 shares — an estimated $1.19M sold.

Element Squared first reported a position in HALO in Q4 2025 and held it in 1 quarter. The position peaked at $1.19M in Q4 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Element Squared reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
Element Squared sold 17,726 Halozyme shares in Q1 2026, an estimated $1.19M.
Element Squared first reported a position in Halozyme in Q4 2025 and held it in 1 quarter.
Element Squared's Halozyme position peaked at $1.19M in Q4 2025.
635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Element Squared's 13F filing for Q1 2026, filed 23 Apr 2026.